Evidence map›Paper›PMID 36188629›Full record

ArticleJournal of herbal medicine2022

A phylogenetic perspective of antiviral species of the genus

Adil Hussain

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of herbal medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. The Antiviral and Antimalarial Prodrug Artemisinin from theCurrent issues in molecular biology · 2024
    Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Adil HussainFood and Biotechnology Research Centre, Pakistan Council of Scientific and Industrial Research (PCSIR) Laboratories Complex, Ferozepur Road, Lahore 54600, Punjab, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Different classes of disease-causing viruses are widely distributed universally. Plant-based medicines are anticipated to be effective cures for viral diseases including the COVID-19, instigated by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2). This study displays the phylogenetic perspective of Methods: Data of Results: In total, 23 Discussion:

Indexed as

Antiviral activityArtemisiaAsteraceaeBVD, Bovine viral diarrhea virusCandidate taxaCOVID-19DEN 2, Dengue virus type 2FCV, Feline calci virusFIV, Feline immunodeficiency virusHBeAg, Hepatitis B e-antigenHBsAg, Hepatitis B surface antigenHBV, Hepatitis B virusHCV, Hepatitis C virusHeLa, Henrietta Lacks cellsHHV-4 (EBV), Human gammaherpesvirus type 4 (Epstein-Barr virus)HHV (HSV), Human alphaherpesvirus (Herpes simplex virus)HIV-, Human immunodeficiency virusITS PhylogenyIV, Influenza virusJUN V, Junin virusMDBK, Madin-Darby bovine kidney cellsMDCK, Madin-Darby canine kidney cellsMNV, Murine norovirusMTTA, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide assayNDV, Newcastle disease virusPV, Polio virusSARS-CoV-2SARS CoV2, Severe acute respiratory syndrome corona virus 2SV, Sindbis virusVERO, Verda reno cellsYFV, Yellow fever virus

Identifiers

PMID36188629
PMCPMC9514968

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.